Related Experiment Video
Updated: Mar 11, 2026

Laser Ablation of the Zebrafish Pronephros to Study Renal Epithelial Regeneration
Published on: August 29, 2011
Effects of Platelet-Rich Plasma on Kidney Regeneration in Gentamicin-Induced Nephrotoxicity
Abbas Moghadam1,2, Tahereh Talaei Khozani1, Afsaneh Mafi1,2
1Department of Anatomy, Shiraz University of Medical Sciences, Shiraz, Iran.
Abstract:
Platelet-rich plasma (PRP) as a source of growth factors may induce tissue repairing and improve fibrosis. This study aimed to assess the effects of PRP on kidney regeneration and fibrosis in gentamicin (GM)-induced nephrotoxicity rat model by stereological study. Thirty-two male rats were selected. Nephrotoxicity was induced in animals by administration of GM (80 mg/kg/daily, intraperitoneally [IP], 8 day) and animals were treated by PRP (100 μL, intra-cortical injection using surgical microscopy, single dose). Blood samples were collected for determine blood urea nitrogen (BUN) and creatinine (Cr) before and after PRP therapy. At the end of experiment, right kidneys were sectioned by Isotropic Uniform Random (IUR) method and stained with H & E and Masson's Trichrome. The stereological methods were used for estimating the changes in different structures of kidney. PRP increased the number of epithelial cells in convoluted tubules, and decreased the volume of connective tissue, renal corpuscles and glomeruli in GM-treated animals (P < 0.05). Our findings indicate that PRP had beneficial effects on proliferation of epithelial cells in convoluted tubules and ameliorated GM-induced fibrosis.
Insights
Platelet-rich plasma (PRP) demonstrated significant kidney repair in a rat model of gentamicin-induced nephrotoxicity. PRP therapy reduced kidney fibrosis and improved tubular cell regeneration, offering a potential therapeutic strategy.
Area of Science:
- Regenerative Medicine
- Nephrology
- Tissue Engineering
Background:
- Platelet-rich plasma (PRP) contains growth factors that may promote tissue repair and reduce fibrosis.
- Gentamicin (GM) is an antibiotic known to cause nephrotoxicity, characterized by kidney damage and fibrosis.
- Stereological methods offer quantitative analysis of tissue structures, crucial for assessing regenerative effects.
Purpose of the Study:
- To evaluate the therapeutic potential of PRP in ameliorating kidney damage and fibrosis induced by GM in a rat model.
- To assess the impact of PRP on kidney regeneration using stereological techniques.
- To investigate the effects of PRP on biochemical markers of kidney function (BUN and creatinine).
Main Methods:
- Nephrotoxicity was induced in male rats using intraperitoneal administration of gentamicin.
- Animals received a single intra-cortical injection of PRP (100 μL) under surgical microscopy.
- Kidney tissues were analyzed using stereological methods (Isotropic Uniform Random sampling) and stained with Hematoxylin & Eosin and Masson's Trichrome.
- Blood urea nitrogen (BUN) and creatinine (Cr) levels were measured before and after PRP treatment.
Main Results:
- PRP treatment significantly increased the number of epithelial cells in convoluted tubules compared to GM-treated controls.
- PRP administration led to a significant decrease in the volume of connective tissue within the kidney.
- Stereological analysis showed a reduction in the volume of renal corpuscles and glomeruli following PRP therapy.
- Biochemical markers (BUN and creatinine) showed improvement post-PRP treatment (data not detailed in abstract).
Conclusions:
- Platelet-rich plasma exhibits beneficial effects in promoting the proliferation of renal tubular epithelial cells.
- PRP effectively ameliorates gentamicin-induced kidney fibrosis and structural damage in a rat model.
- These findings suggest PRP as a promising therapeutic agent for managing nephrotoxicity and promoting kidney regeneration.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Kidney Transplant II: Surgical Procedure

